医学
年轻人
嵌合抗原受体
肿瘤科
微小残留病
疾病
免疫学
总体生存率
疾病负担
细胞因子释放综合征
内科学
免疫疗法
儿科
淋巴细胞白血病
急性淋巴细胞白血病
疾病负担
梅德林
耐火材料(行星科学)
白血病
抗原
受体
作者
Liora M. Schultz,Christina Baggott,Snehit Prabhu,Holly L. Pacenta,Christine L. Phillips,Jenna Rossoff,Heather E. Stefanski,Julie-An Talano,Amy Moskop,Steven P. Margossian,Michael R. Verneris,Gary Douglas Myers,Nicole A. Karras,Patrick A. Brown,Muna Qayed,Michelle Hermiston,Prakash Satwani,Christa Krupski,Amy K. Keating,Rachel Wilcox
摘要
Commercial tisagenlecleucel in CAYA RR B-ALL demonstrates efficacy and tolerability. This first analysis of commercial tisagenlecleucel stratified by disease burden identifies HB preinfusion to associate with inferior OS and EFS and increased toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI